Artículos por temáticas

Executive and Visuospatial Dysfunction in Patients With Primary Restless Legs Syndrome/Willis-Ekbom Disease: Study of a Chinese Population.

Li G, Tang H, Chen J, Qi X, Chen S, Ma J.

J Clin Sleep Med. 2018 May 15;14(5):785-790. doi: 10.5664/jcsm.7106.

Restless legs syndrome: a rarity in the Nigerian pregnant population?

Fawale MB, Ismaila IA, Kullima AA, Komolafe MA, Ijarotimi OA, Olowookere SA, Oluyombo R, Adedeji TA.

Sleep Med. 2018 Mar;43:47-53. doi: 10.1016/j.sleep.2018.01.002. Epub 2018 Jan 31.

The Association Between Vitamin D Level and Restless Legs Syndrome: A Population-Based Case-Control Study.

Wali S, Alsafadi S, Abaalkhail B, Ramadan I, Abulhamail B, Kousa M, Alshamrani R, Faruqui H, Faruqui A, Alama M, Hamed M.

J Clin Sleep Med. 2018 Mar 30. pii: jc-17-00496. [Epub ahead of print]

Diurnal variation of default mode network in patients with restless legs syndrome.

Ku J, Lee YS, Chang HW, Earley CJ, Allen RP, Cho YW.

Sleep Med. 2018 Jan;41:1-8. doi: 10.1016/j.sleep.2017.09.031. Epub 2017 Oct 25.

Patients with primary restless legs syndrome have higher prevalence of autonomic dysfunction and irritable bowel syndrome.

Acar BA, Acar MAG, Acar T, Varım C, Alagöz AN, Demiryürek EB, Doğan Güngen B, Güzey Aras Y.

Singapore Med J. 2018 Jan 26. doi: 10.11622/smedj.2018010. [Epub ahead of print]

Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial.

Wali SO, Abaalkhail B, Alhejaili F, Pandi-Perumal SR.

Sleep Breath. 2018 Nov 14. doi: 10.1007/s11325-018-1751-2. [Epub ahead of print]

Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study.

Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B.

Toxins (Basel). 2018 Sep 29;10(10). pii: E401. doi: 10.3390/toxins10100401.

High-Resolution Nerve Ultrasound and Electrophysiological Findings in Restless Legs Syndrome.

Pitarokoili K, Fels M, Kerasnoudis A, Toenges L, Gold R, Yoon MS.

J Neuroimaging. 2018 May 11. doi: 10.1111/jon.12520. [Epub ahead of print]

Connecting clinical aspects to corticomotor excitability in restless legs syndrome: a TMS study.

Salas RME, Kalloo A, Earley CJ, Celnik P, Cruz TE, Foster K, Cantarero G, Allen RP.

Sleep Med. 2018 Sep;49:105-112. doi: 10.1016/j.sleep.2018.05.002. Epub 2018 May 31.

Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.

Kim J, Hartzema AG.

Sleep Med. 2018 Apr;44:45-52. doi: 10.1016/j.sleep.2017.11.1139. Epub 2017 Dec 14.

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.

Silber MH, Becker PM, Buchfuhrer MJ, Earley CJ, Ondo WG, Walters AS, Winkelman JW; Scientific and Medical Advisory Board, Restless Legs Syndrome Foundation..

Mayo Clin Proc. 2018 Jan;93(1):59-67. doi: 10.1016/j.mayocp.2017.11.007.

Restless Legs Syndrome in Iranian People With Type 2 Diabetes Mellitus: The Role in Quality of Life and Quality of Sleep.

Modarresnia L, Golgiri F, Madani NH, Emami Z, Tanha K.

J Clin Sleep Med. 2018 Feb 15;14(2):223-228. doi: 10.5664/jcsm.6938.

Treatment of Comorbid Obstructive Sleep Apnea by Upper Airway Stimulation Results in Resolution of Debilitating Symptoms of Restless Legs Syndrome.

Myc LA, Churnin IT, Jameson MJ, Davis EM.

J Clin Sleep Med. 2018 Oct 1. pii: jc-18-00342. [Epub ahead of print]

Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome.

Yilmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A.

Neuropsychiatr Dis Treat. 2018 Aug 29;14:2207-2214. doi: 10.2147/NDT.S174552. eCollection 2018.

Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.

Meneely S, Dinkins ML, Kassai M, Lyu S, Liu Y, Lin CT, Brewer K, Li Y, Clemens S.

Front Behav Neurosci. 2018 Sep 4;12:199. doi: 10.3389/fnbeh.2018.00199. eCollection 2018.